Roivant Sciences (ROIV) Return on Capital Employed (2021 - 2025)

Roivant Sciences (ROIV) reported Return on Capital Employed of 25.77% for Q4 2025, down 10354.0% on a YoY basis from N/an in Q4 2024, and down 4.89% quarter-over-quarter from 24.57% in Q3 2025.

Roivant Sciences (ROIV) Return on Capital Employed (2021 - 2025) Analysis & Trends

Roivant Sciences has reported Return on Capital Employed for 5 years, with the latest figure at 25.77% in Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 10354.0% year-over-year to 25.77%; the trailing twelve-month figure through Dec 2025 stood at 25.77% (down 10354.0% YoY), and the FY2026 full-year result was 9.93%, up 843.0% from the prior year.
  • Return on Capital Employed for Q4 2025 stood at 25.77%, down from 24.57% in the prior quarter.
  • The five-year high for Return on Capital Employed was 97.28% in Q4 2023, with the low at 68.6% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 12.68% across 5 years, with a median of 29.59% in 2021.
  • Annual changes were most pronounced in 2023 — Return on Capital Employed surged 15770 bps — and 2025, when it plunged 10354 bps.
  • Roivant Sciences' Return on Capital Employed stood at 48.16% in 2021, then slipped by 25 bps to 60.42% in 2022, then surged by 261 bps to 97.28% in 2023, then declined by 20 bps to 77.77% in 2024, then tumbled by 133 bps to 25.77% in 2025.
  • The last three Return on Capital Employed figures came in at 25.77% (Q4 2025), 24.57% (Q3 2025), and 19.59% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Roivant Sciences 21.82 Bn 22.59 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -25.77%
Sep 30, 2025 -24.57%
Jun 30, 2025 -19.59%
Dec 31, 2024 77.77%
Sep 30, 2024 77.13%
Jun 30, 2024 68.25%
Dec 31, 2023 97.28%
Sep 30, 2023 -62.61%
Jun 30, 2023 -60.33%
Dec 31, 2022 -60.42%
Sep 30, 2022 -68.60%
Jun 30, 2022 -60.39%
Dec 31, 2021 -48.16%
Sep 30, 2021 -50.68%
Jun 30, 2021 -29.59%